US3908012A
(en)
|
1970-10-05 |
1975-09-23 |
Pfizer |
Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
|
US3707560A
(en)
|
1970-10-05 |
1972-12-26 |
Pfizer |
Certain 4-amino-6-aryl-pyrimidines
|
FR2204406A1
(en)
|
1972-10-26 |
1974-05-24 |
Delalande Sa |
1-Phenyl-3-aminocarbonylpropan-1-one oxime carbamates - with analgesic, antiinflammatory, hypotensive and sedative activities etc.
|
US3950525A
(en)
|
1973-06-19 |
1976-04-13 |
Pfizer Inc. |
Relaxation of smooth muscle in a mammal
|
US3935202A
(en)
|
1974-03-18 |
1976-01-27 |
American Home Products Corporation |
3-(4-biphenylylcarbonyl)propionamido cephalosporin derivatives
|
US4634689A
(en)
|
1985-10-31 |
1987-01-06 |
Schering Corporation |
Phosphinylalkanoyl imino acids
|
DE3609596A1
(de)
|
1986-03-21 |
1987-10-01 |
Hoechst Ag |
2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
|
US4931443A
(en)
|
1986-10-27 |
1990-06-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Piperazine compound and pharmaceutical use thereof
|
ZW21687A1
(en)
|
1986-12-12 |
1988-07-20 |
Hoffmann La Roche |
Triazine derivatives
|
JPH01113377A
(ja)
|
1987-10-23 |
1989-05-02 |
Yoshitomi Pharmaceut Ind Ltd |
ピペラジン化合物
|
MX16687A
(es)
|
1988-07-07 |
1994-01-31 |
Ciba Geigy Ag |
Compuestos de biarilo y procedimiento para su preparacion.
|
US5102904A
(en)
|
1989-12-08 |
1992-04-07 |
American Cyanamid Company |
N-oxygenated arylpyrrole insecticidal, acaricidal and nematicidal agents and use thereas
|
AU644159B2
(en)
|
1990-05-17 |
1993-12-02 |
Novartis Ag |
2-anilino-4-cyanopyrimidine derivatives
|
DE4103695A1
(de)
|
1991-02-07 |
1992-08-13 |
Basf Ag |
Oximether und diese enthaltende fungizide
|
US5334720A
(en)
|
1991-03-07 |
1994-08-02 |
Fisons Corporation |
Diphenyl-1-(aminoalkyl)-2-piperidinone and -2-pyrrolidinone derivatives having anticonvulsant properties
|
WO1995023135A1
(en)
|
1991-03-07 |
1995-08-31 |
Fisons Corporation |
Diphenyl-2-piperidinone and -2-pyrrolidinone derivatives having anti-convulsant and neuroprotective activity
|
JPH0741459A
(ja)
|
1993-07-29 |
1995-02-10 |
Sumitomo Pharmaceut Co Ltd |
新規エラスターゼ阻害剤
|
ES2147210T3
(es)
|
1993-12-03 |
2000-09-01 |
Hoffmann La Roche |
Derivados de acido acetico como medicamentos.
|
US5338739A
(en)
|
1994-03-10 |
1994-08-16 |
Hoechst-Roussel Pharmaceuticals Inc. |
(Pyrrolidinyl)phenyl carbamates, compositions and use
|
DE4430639A1
(de)
|
1994-08-29 |
1996-03-07 |
Bayer Ag |
Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten
|
FR2732017B1
(fr)
|
1995-03-21 |
2000-09-22 |
Inst Nat Sante Rech Med |
Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
|
JP2000500755A
(ja)
|
1995-11-17 |
2000-01-25 |
バイエル・アクチエンゲゼルシヤフト |
ビフェニルエーテルオキサゾリン及びその有害生物防除剤としての使用
|
ES2175155T3
(es)
|
1995-12-22 |
2002-11-16 |
Warner Lambert Co |
Cetoacidos aromaticos y sus derivados como inhibidores de las metaloproteinasas matriciales.
|
DE19600934A1
(de)
|
1996-01-12 |
1997-07-17 |
Basf Ag |
Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
|
AU4159197A
(en)
|
1996-09-04 |
1998-03-26 |
Warner-Lambert Company |
Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
IL128545A0
(en)
|
1996-12-09 |
2000-01-31 |
Warner Lambert Co |
Method for treating and preventing heart failure and ventricular dilatation
|
JP2001507342A
(ja)
|
1996-12-17 |
2001-06-05 |
ワーナー−ランバート・コンパニー |
神経疾患の治療および創傷治癒を促進するためのマトリックスメタロプロテイナーゼ阻害剤の使用
|
JP2001511813A
(ja)
|
1997-02-18 |
2001-08-14 |
ニューロクライン バイオサイエンシーズ,インコーポレイテッド |
Crfレセプターアンタゴニストおよびそれらに関連する方法
|
CN1100777C
(zh)
|
1997-02-19 |
2003-02-05 |
伯莱克斯实验室公司 |
作为nos抑制剂的n-杂环衍生物
|
US5925639A
(en)
|
1997-06-17 |
1999-07-20 |
Schering Corporation |
Keto amide derivatives useful as farnesyl protein transferase inhibitors
|
AU9663798A
(en)
|
1997-10-06 |
1999-04-27 |
Warner-Lambert Company |
Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
WO1999021583A1
(en)
|
1997-10-29 |
1999-05-06 |
Warner-Lambert Company |
Method of inhibiting metastases of cancer cells
|
BR9814422A
(pt)
|
1997-12-23 |
2000-10-10 |
Warner Lambert Co |
Combinações de inibidor de ace - inibidor de mmp
|
US6169103B1
(en)
|
1998-03-03 |
2001-01-02 |
Warner-Lambert |
Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
AU766831B2
(en)
|
1998-05-11 |
2003-10-23 |
Takeda Pharmaceutical Company Limited |
Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
|
US6288063B1
(en)
|
1998-05-27 |
2001-09-11 |
Bayer Corporation |
Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
|
WO2000018738A1
(en)
|
1998-09-25 |
2000-04-06 |
Astrazeneca Ab |
Benzamide derivatives and their use as cytokine inhibitors
|
JP4183350B2
(ja)
|
1998-10-28 |
2008-11-19 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
フェニルピロリジノン誘導体
|
US6541521B1
(en)
|
1999-07-12 |
2003-04-01 |
Warner-Lambert Company |
Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
WO2001032608A1
(fr)
|
1999-10-29 |
2001-05-10 |
Takeda Chemical Industries, Ltd. |
Procédé de préparation de dérivés d'acide oxyminoalcanoïque
|
KR20020060227A
(ko)
|
1999-11-10 |
2002-07-16 |
다케다 야쿠힌 고교 가부시키가이샤 |
체중 증가 억제제
|
AU1303201A
(en)
|
1999-11-10 |
2001-06-06 |
Takeda Chemical Industries Ltd. |
Alkoxyiminoalkanoic acid derivatives
|
GB0003671D0
(en)
|
2000-02-17 |
2000-04-05 |
Univ Cardiff |
Diphenyl-substituted lower alkanes
|
CY2010012I2
(el)
|
2000-05-25 |
2020-05-29 |
Novartis Ag |
Μιμητικα θρομβοποιητινης
|
EP1340749A4
(en)
|
2000-11-17 |
2007-09-05 |
Takeda Pharmaceutical |
isoxazole
|
HUP0302526A2
(hu)
|
2000-12-21 |
2003-11-28 |
Glaxo Group Limited |
Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
|
US6610723B2
(en)
|
2001-01-29 |
2003-08-26 |
Hoffmann-La Roche Inc. |
Imidazole derivatives
|
JP2002241358A
(ja)
|
2001-02-15 |
2002-08-28 |
Nippon Soda Co Ltd |
オキシム基を有する化合物及び殺虫・殺ダニ剤
|
AR035858A1
(es)
|
2001-04-23 |
2004-07-21 |
Bayer Corp |
Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3
|
EP1394147A4
(en)
|
2001-06-04 |
2007-10-24 |
Eisai R&D Man Co Ltd |
CARBOXYLENE DERIVATIVE AND A SALT OR AN ESTER CONTAINING MEDICINE
|
CA2450589C
(en)
|
2001-06-08 |
2011-12-20 |
Cytokine Pharmasciences, Inc. |
Isoxazoline compounds having mif antagonist activity
|
US6552188B2
(en)
|
2001-06-29 |
2003-04-22 |
Kowa Co., Ltd. |
Unsymmetrical cyclic diamine compound
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
AR037233A1
(es)
|
2001-09-07 |
2004-11-03 |
Euro Celtique Sa |
Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
|
AU2002341921B2
(en)
|
2001-10-04 |
2007-05-31 |
Merck Sharp & Dohme Corp. |
Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
JP4286146B2
(ja)
|
2001-12-18 |
2009-06-24 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピラゾール系調節剤
|
US6949542B2
(en)
|
2002-02-06 |
2005-09-27 |
Hoffman-La Roche Inc. |
Dihydro-benzo[b][1,4]diazepin-2-one derivatives
|
US7122580B2
(en)
|
2002-08-09 |
2006-10-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
AU2003266528A1
(en)
|
2002-09-20 |
2004-04-08 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound, process for producing the same, and use
|
WO2004032933A1
(ja)
|
2002-10-11 |
2004-04-22 |
Kowa Co., Ltd. |
癌の処置方法
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
HU230612B1
(hu)
|
2002-11-27 |
2017-04-28 |
Incyte Corporation |
Kemokin receptorokat módosító hatású 3-aminopirrolidin-származékok
|
AU2003297431A1
(en)
|
2002-12-20 |
2004-07-22 |
Pharmacia Corporation |
Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
|
WO2004060872A1
(en)
|
2002-12-30 |
2004-07-22 |
Eli Lilly And Company |
Factor xa inhibitors
|
US20040180332A1
(en)
*
|
2003-03-12 |
2004-09-16 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating aids and HIV-related disorders using 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735, 1786, 10220, 17822, 33945, 43748, 47161, 81982 or 46777
|
CA2519677A1
(en)
|
2003-03-24 |
2004-10-07 |
Merck & Co., Inc. |
Biaryl substituted 6-membered heterocycles as sodium channel blockers
|
AU2003902860A0
(en)
|
2003-06-06 |
2003-06-26 |
Daicel Chemical Industries, Ltd |
Benzimidazole compounds
|
CN1566065A
(zh)
|
2003-06-27 |
2005-01-19 |
中国医学科学院药物研究所 |
α位杂原子取代的γ芳基丁本酮酸衍生物及其制法和其药物组合物与用途
|
SE0301963D0
(sv)
|
2003-07-02 |
2003-07-02 |
Astrazeneca Ab |
New compounds
|
AU2004261587B2
(en)
|
2003-07-25 |
2008-02-21 |
Amgen Inc. |
Substituted pyridones and pyrimidinones with antiinflammatory properties
|
US7420083B2
(en)
|
2003-09-25 |
2008-09-02 |
Wyeth |
Substituted aryloximes
|
GB0323581D0
(en)
|
2003-10-08 |
2003-11-12 |
Glaxo Group Ltd |
Novel compounds
|
WO2005040135A1
(ja)
|
2003-10-24 |
2005-05-06 |
Ono Pharmaceutical Co., Ltd. |
抗ストレス薬およびその医薬用途
|
AU2004285052A1
(en)
|
2003-10-31 |
2005-05-12 |
Neurogen Corporation |
4-amino (AZA) quinoline derivatives as capsaicin receptor agonists
|
CN1933838A
(zh)
|
2004-02-12 |
2007-03-21 |
默克公司 |
作为代谢型谷氨酸受体-5调节剂的联吡啶酰胺
|
GB0403155D0
(en)
|
2004-02-12 |
2004-03-17 |
Vernalis Res Ltd |
Chemical compounds
|
CA2557166C
(en)
|
2004-03-26 |
2015-06-30 |
Cytokine Pharmasciences, Inc. |
Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
|
RU2403252C2
(ru)
|
2004-03-30 |
2010-11-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Азаиндолы, полезные в качестве ингибиторов jak и других протеинкиназ
|
AU2005256442B2
(en)
|
2004-06-28 |
2009-02-12 |
F. Hoffmann-La Roche Ag |
Pyrimidine derivatives as 11beta-HSD1 inhibitors
|
EP1786781A2
(en)
|
2004-08-27 |
2007-05-23 |
GPC Biotech AG |
Pyrimidine derivatives
|
KR20070045272A
(ko)
|
2004-08-27 |
2007-05-02 |
아스텔라스세이야쿠 가부시키가이샤 |
2-페닐피리딘 유도체
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
SE0402735D0
(sv)
|
2004-11-09 |
2004-11-09 |
Astrazeneca Ab |
Novel compounds
|
ZA200704789B
(en)
|
2004-12-07 |
2008-11-26 |
Toyoma Chemical Co Ltd |
Novel anthranilic acid derivative or salt thereof
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
US7468383B2
(en)
|
2005-02-11 |
2008-12-23 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
EP2457901A1
(en)
|
2005-03-14 |
2012-05-30 |
High Point Pharmaceuticals, LLC |
Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
|
EP2605013A1
(en)
|
2005-06-07 |
2013-06-19 |
The Rockefeller University |
Stimulation of pancreatic beta-cell proliferation
|
CA2617532A1
(en)
|
2005-08-04 |
2007-02-15 |
Sirtris Pharmaceuticals, Inc. |
Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
WO2007017289A2
(en)
|
2005-08-10 |
2007-02-15 |
Bayer Schering Pharma Aktiengesellschaft |
Acyltryptophanols for fertility control
|
BRPI0615133A2
(pt)
|
2005-08-23 |
2011-05-03 |
Irm Llc |
compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso
|
TW200745055A
(en)
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
SI2395002T1
(sl)
|
2005-11-08 |
2014-10-30 |
Vertex Pharmaceuticals Incorporated |
Farmacevtski sestavek, vsebujoč heterociklični modulator prenašalcev z ATP-vezavno kaseto
|
EP1960367A2
(en)
|
2005-12-05 |
2008-08-27 |
Boehringer Ingelheim International GmbH |
Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
|
JP2009519966A
(ja)
|
2005-12-14 |
2009-05-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
セリンプロテアーゼ阻害剤として有用な6員ヘテロ環
|
WO2007087637A2
(en)
|
2006-01-26 |
2007-08-02 |
Washington State University Research Foundation |
Compositions and methods using matrix metalloproteinase (mmp) inhibitors for treating cognitive impairment characterized by persistent or sustained mmp expression and/or activity
|
US7951824B2
(en)
|
2006-02-17 |
2011-05-31 |
Hoffman-La Roche Inc. |
4-aryl-pyridine-2-carboxyamide derivatives
|
ES2303758B1
(es)
|
2006-02-20 |
2009-08-13 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridin-3-amina.
|
WO2007097403A1
(ja)
|
2006-02-24 |
2007-08-30 |
Astellas Pharma Inc. |
消化管潰瘍治療又は予防薬
|
JP2007230963A
(ja)
|
2006-03-03 |
2007-09-13 |
Daiso Co Ltd |
2,4−ジ置換ピリジンの製造法
|
EP2327696A1
(en)
|
2006-06-26 |
2011-06-01 |
Warner Chilcott Company, LLC |
Prolyl hydroxylase inhibitors and methods of use
|
GB0614579D0
(en)
*
|
2006-07-21 |
2006-08-30 |
Black James Foundation |
Pyrimidine derivatives
|
WO2008017691A1
(en)
|
2006-08-10 |
2008-02-14 |
Glaxo Group Limited |
Pyridine derivatives as sodium channel blockers
|
WO2008022281A1
(en)
|
2006-08-16 |
2008-02-21 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Small molecule inhibitors of kynurenine-3-monooxygenase
|
EP2054056A4
(en)
|
2006-08-16 |
2010-08-25 |
J David Gladstone Inst A Testa |
SMALL MOLECULAR INHIBITORS OF KYNURENINE-3-MONOOXYGENASE
|
US20110172230A1
(en)
|
2006-08-23 |
2011-07-14 |
Takahiro Ishii |
Urea compound or salt thereof
|
CN101511796B
(zh)
|
2006-09-05 |
2012-05-09 |
协和发酵麒麟株式会社 |
咪唑衍生物
|
US8188113B2
(en)
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US20080077419A1
(en)
|
2006-09-27 |
2008-03-27 |
Santiago Pamela M |
System And Method For Training Employees Of An Organization To Align Their Job Activities To Achieving The Organization's Strategic Objectives
|
US8735411B2
(en)
|
2006-10-02 |
2014-05-27 |
Abbvie Inc. |
Macrocyclic benzofused pyrimidine derivatives
|
BRPI0719221A2
(pt)
|
2006-10-12 |
2014-03-18 |
Novartis Ag |
Derivados de pirrolidina como inibidores de iap
|
WO2008095852A1
(en)
|
2007-02-08 |
2008-08-14 |
Respiratorius Ab |
Bronchorelaxing arylamides
|
EA019893B1
(ru)
*
|
2007-02-23 |
2014-07-30 |
Джилид Сайэнс, Инк. |
Фармацевтическая композиция и способ лечения вич-инфекции
|
WO2008120810A1
(ja)
|
2007-03-29 |
2008-10-09 |
Sumitomo Chemical Company, Limited |
化合物、光電変換素子及び光電気化学電池
|
KR20100016073A
(ko)
|
2007-04-02 |
2010-02-12 |
인스티튜트 포 원월드 헬스 |
Cftr 억제제 화합물 및 이의 용도
|
EP2002834A1
(de)
|
2007-06-13 |
2008-12-17 |
Bayer Schering Pharma Aktiengesellschaft |
Aryl/Hetarylamide als Modulatoren des EP2-Rezeptors
|
TWI444379B
(zh)
|
2007-06-29 |
2014-07-11 |
Sunesis Pharmaceuticals Inc |
有用於作為Raf激酶抑制劑之化合物
|
PE20091309A1
(es)
|
2007-12-21 |
2009-09-30 |
Astrazeneca Ab |
Derivados de ciclohexilo como inhibidores de acetil coenzima a carboxilasa
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
EP2291187B1
(en)
*
|
2008-04-24 |
2018-08-15 |
Newlink Genetics Corporation |
Ido inhibitors
|
JP2009280521A
(ja)
|
2008-05-22 |
2009-12-03 |
Daiso Co Ltd |
2,4−ジ置換ピリジンの製造法
|
JP2011184298A
(ja)
|
2008-06-02 |
2011-09-22 |
Sanwa Kagaku Kenkyusho Co Ltd |
新規化合物及びその医薬用途
|
KR101927291B1
(ko)
*
|
2008-07-08 |
2018-12-10 |
인사이트 홀딩스 코포레이션 |
인돌아민 2,3-디옥시게나아제의 억제제로서의 1,2,5-옥사디아졸
|
WO2010005783A1
(en)
|
2008-07-08 |
2010-01-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
|
US20110230428A1
(en)
|
2008-07-22 |
2011-09-22 |
John Wityak |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
MX2010014337A
(es)
|
2008-07-25 |
2011-02-15 |
Lundbeck & Co As H |
Derivados de adamantil diamida y usos de los mismos.
|
US8691824B2
(en)
|
2008-08-04 |
2014-04-08 |
Chdi Foundation, Inc. |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
US8536186B2
(en)
*
|
2008-08-04 |
2013-09-17 |
Chdi Foundation, Inc. |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
WO2010044404A1
(ja)
|
2008-10-15 |
2010-04-22 |
キッセイ薬品工業株式会社 |
縮合複素環誘導体及びその医薬用途
|
EP2340243B1
(en)
|
2008-10-17 |
2014-10-08 |
Boehringer Ingelheim International GmbH |
Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
|
WO2010052448A2
(en)
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
EP2356107A1
(en)
|
2008-11-13 |
2011-08-17 |
Bayer Cropscience Ag |
Substituted (pyridyl)-azinylamine derivatives as fungicides
|
GEP20135992B
(en)
|
2009-01-12 |
2013-12-25 |
Icagen Inc |
Sulfonamide derivatives
|
WO2010100475A1
(en)
|
2009-03-02 |
2010-09-10 |
Astrazeneca Ab |
Hydroxamic acid derivatives as gram-negative antibacterial agents
|
CN102459246B
(zh)
|
2009-04-07 |
2014-05-07 |
阿斯利康(瑞典)有限公司 |
作为治疗剂的异噁唑-3(2h)-酮类似物
|
PT2424843E
(pt)
|
2009-04-30 |
2014-06-02 |
Novartis Ag |
Derivados de imidazol e seu uso como moduladores de quinases dependentes de ciclina
|
US20120041009A1
(en)
|
2009-05-18 |
2012-02-16 |
Sumitomo Chemical Company, Limited |
Pyrimidine compound and its use in pest control
|
TWI491606B
(zh)
|
2009-07-13 |
2015-07-11 |
Gilead Sciences Inc |
調節細胞凋亡信號之激酶的抑制劑
|
TWI423962B
(zh)
|
2009-10-07 |
2014-01-21 |
Lg Life Sciences Ltd |
有效作為黃嘌呤氧化酶抑制劑之新穎化合物、其製備方法及含該化合物之醫藥組成物
|
JP5099731B1
(ja)
|
2009-10-14 |
2012-12-19 |
メルク・シャープ・アンド・ドーム・コーポレーション |
p53活性を増大する置換ピペリジン及びその使用
|
WO2011050323A1
(en)
|
2009-10-22 |
2011-04-28 |
The Washington University |
Compounds and methods for treating bacterial infections
|
US8946197B2
(en)
|
2009-11-16 |
2015-02-03 |
Chdi Foundation, Inc. |
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
|
BR112012018500A2
(pt)
|
2010-01-25 |
2016-08-16 |
Chdi Foundation Inc |
alguns inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso destas
|
RS56312B1
(sr)
|
2010-02-27 |
2017-12-29 |
Bayer Ip Gmbh |
Ariltriazoloni spojeni sa bis-arilom i njihova upotreba
|
TWI535442B
(zh)
*
|
2010-05-10 |
2016-06-01 |
Kyowa Hakko Kirin Co Ltd |
A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine
|
KR101759759B1
(ko)
|
2010-07-02 |
2017-07-19 |
길리애드 사이언시즈, 인코포레이티드 |
세포자멸사 신호-조절 키나아제 저해제
|
WO2012035421A2
(en)
|
2010-09-17 |
2012-03-22 |
Purdue Pharma L.P. |
Pyridine compounds and the uses thereof
|
EP2796456A1
(en)
|
2010-12-09 |
2014-10-29 |
Amgen Inc. |
Bicyclic compounds as Pim inhibitors
|
JP2014521651A
(ja)
|
2011-07-28 |
2014-08-28 |
シーエイチディーアイ ファウンデーション,インコーポレーテッド |
特定のキヌレニン−3−モノオキシゲナーゼインヒビターおよびその医薬組成物ならびにこれらの使用方法
|
HUE034802T2
(en)
*
|
2011-08-30 |
2018-02-28 |
Chdi Foundation Inc |
Kinurenin-3-monooxygenase inhibitors, pharmaceutical preparations and methods of use
|
SG2014011654A
(en)
*
|
2011-08-30 |
2014-08-28 |
Chdi Foundation Inc |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
EA201491606A1
(ru)
|
2012-04-05 |
2015-03-31 |
Схди Фаундейшн, Инк. |
Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
|
US9938252B2
(en)
|
2013-09-26 |
2018-04-10 |
Chdi Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
US9884853B2
(en)
|
2013-09-26 |
2018-02-06 |
Chdi Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|